SDGR: Schrödinger Inc. Price-to-Revenue Coefficient

Symbol and logo of brand Schrödinger Inc. (SDGR)

Schrodinger, Inc. (SDGR) is scaling its cloud SaaS service, combining licensing revenue with the development of its own proprietary drug candidates. The price-to-sales valuation reflects investor reaction to this growth, where 7.50 captures the current value of the indicator. Quantum modeling and AI are radically accelerating molecule discovery, while steady demand for software ensures the business remains resilient to economic shocks.

SDGR (Schrodinger, Inc.) P/S Multiple history from 07/04/2022 to 11/13/2026

Metric breakdowns and analytics for Schrödinger Inc. (SDGR)

- stock price and consensus target price:
Summary company analytics:schrodinger.com, SDGR
Mass-produced product of Schrodinger Corp

The scalability of Schrodinger, Inc. (SDGR) licensed software creates powerful operating leverage, allowing high-margin software sales to effectively offset biotech laboratory costs. The ratio of market capitalization to annual revenue measures the cost of each dollar of sales, which enables an assessment of whether the business is overvalued or undervalued by analyzing the historical P/S chart for market distortions and bubbles.

Competing companies

veeva.com - Market Cap to Revenue Ratio|P/S Multiple DOCS (Doximity)|Price-to-Revenue Coefficient HealthEquity Inc (HQY)|WAY - Price-to-Revenue Ratio|CRVL (CorVel Corp.) - Market Cap to Revenue Ratio|PRVA: P/S Multiple|Price-to-Revenue Multiple huronconsultinggroup.com HURN|CERT (Certara) - P/S Multiple|Price to Sales Omnicell Inc OMCL|Price-to-Revenue Ratio GoodRx Corp (GDRX)|PHR (Phreesia Health) - Market Capitalization-to-Revenue Ratio|Omada Health Inc - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio EVH|HealthStream - P/S Multiple|Price-to-Revenue Coefficient Definitive Healthcare Corp DH|Consensus (CCSI) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio AGL|ABSI (Absci) - P/S Multiple|Market Cap to Revenue soyoung.com (SY)|Market Cap to Revenue NRC (nrchealth.com)|Price-to-Revenue Coefficient Spok Holdings Inc|Price-to-Revenue Ratio OptimizeRx Corp. OPRX|Price-to-Revenue Coefficient TruBridge Corp (TBRG)|Simulations Plus, Inc. - P/S Multiple|SOPH (SOPHiA GENETICS SA) - Market Cap to Revenue Ratio|HCAT: P/S Multiple|Price-to-Revenue Multiple CareCloud CCLD|Price-to-Revenue Ratio Research Solutions, Inc.|DLHC: Market Capitalization-to-Revenue Ratio|P/S Multiple ONMD|Price-to-Revenue Coefficient scienture.com|Healthcare Triangle, Inc. - Market Cap to Revenue|Market Cap to Sales Volume ISPC (iSpecimen Inc)|BFRG: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio WORX (SCWorx Inc)|MSP Recovery Inc (MSPR) - Price-to-Revenue Ratio|Market Cap to Revenue iCoreConnect|MEDS (TRxADE HEALTH) - P/S Multiple|Price to Sales Orgenesis Inc ORGS|P/S Multiple RCM|Sharecare Inc - Market Cap to Revenue Ratio|Price-to-Revenue Ratio Streamline Health Solutions STRM|Price-to-Revenue Coefficient syrahealth.com (SYRA)|ApolloMed - P/S Multiple|Model N Inc (MODN) - Market Cap to Revenue|NXGN: P/S Multiple